(IN BRIEF) In early 2024, Europe's medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like…
(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could…
(IN BRIEF) Roche has released positive long-term follow-up data from the Phase III KATHERINE study, evaluating Kadcyla® (trastuzumab emtansine) as…
(IN BRIEF) AstraZeneca has unveiled data from four pivotal Phase III trials at the European Society for Medical Oncology (ESMO)…
(IN BRIEF) GlaxoSmithKline (GSK) has announced a confidential settlement in the Cantlay/Harper case filed in California state court, which was…
(IN BRIEF) The European Investment Bank (EIB) has signed a €10 million loan agreement with Polish company SDS Optic Inc.…
(IN BRIEF) Assistant Professor Annemieke Witteveen, from the Biomedical Signals and Systems department at the Faculty of EEMCS (TechMed Centre),…
(IN BRIEF) Researchers from the Paul Scherrer Institute (PSI) and ETH Zurich, along with the Baden Cantonal Hospital and University…
(IN BRIEF) AstraZeneca's new drug application (NDA) for capivasertib, in combination with Faslodex, has been accepted and granted Priority Review…
(IN BRIEF) M&S has unveiled an art installation called "Sixteen" on London's South Bank. Created in partnership with female body…
SWINDON, 02-Nov-2018 — /EuropaWire/ — A collaboration of researchers from the UK is pursuing a technique to detect breast cancer more…
MONALEESA-7 met primary endpoint of progression-free survival, demonstrating superior efficacy of Kisqali combination therapy vs. endocrine treatment alone in first-line treatment…
YORK, 21-Jul-2017 — /EuropaWire/ — A leading scientist at the University of York is to investigate whether a change in the…
New research by a psychologist at the University of York and colleagues at Brigham and Women’s Hospital in Boston, MA,…
5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to…